Active Pharmaceutical Ingredients (Api) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020

Transparency Market Research

Active Pharmaceutical Ingredients (API) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Published Date 2015-03-24

137 Page Report

Buy Now

Request Sample

Press Release

Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 billion Globally in 2020

Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com

Active Pharmaceutical Ingredients (API) Market

REPORT DESCRIPTION

Active Pharmaceutical Ingredients (API) Market

- Global Industry Analysis,

Size, Share, Growth, Trends and Forecast 2014 – 2020

According to a new market report published by Transparency Market Research "Active Pharmaceutical Ingredients (API) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020," the global active pharmaceutical ingredients market was valued at USD 119.7 billion in 2013 and is anticipated to reach USD 185.9 billion by 2020, expanding at a CAGR of 6.5% during the forecast period from 2014 to 2020.

According to the World Health Organization (WHO), in 2012, cancer was among the leading causes of morbidity and mortality worldwide, with approximately 14 million newly diagnosed cases and 8.2 million cancer-related deaths. Therefore, the oncology segment is expected to be fastest growing segment in the global API market. Moreover, most of the drugs in this segment contain High Potency Active Pharmaceutical Ingredients (HPAPIs) which itself is a rapidly growing segment in the global API market. The market growth of this segment will be particularly higher than other segments owing to loss of patent protection for blockbuster drugs such as Herceptin (Roche), Arimidex (AstraZeneca), Xeloda (Roche), Abraxane (Celgene), Temodar (Merck & Co.) and Vidaza (Celgene) between 2010 and 2014.

Browse the full Active Pharmaceutical...